ORBIS BIOSCIENCES
LIVE

Serial Number

86382988

Owner

Adare Pharmaceuticals USA, Inc.

Attorney

C. Blair Barbieri

First Use Date

Sep 4, 2008

Filing Date

Sep 2, 2014

Add to watchlist:

No watchlists yet
View on USPTO

ORBIS BIOSCIENCES Trademark

Serial Number: 86382988 • Registration: 4869227

ORBIS BIOSCIENCES is a trademark filed by Adare Pharmaceuticals USA, Inc. on September 2, 2014. The trademark is classified under Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Adare Pharmaceuticals USA, Inc. (5 trademarks)

7722 Dungan Road
Philadelphia, PA 19111

Entity Type: 03

Orbis Biosciences, Inc. (6 trademarks)

2002 West 39th Avenue
Kansas City, KS 66103

Entity Type: 03

Trademark Details

Filing Date

September 2, 2014

Registration Date

December 15, 2015

First Use Anywhere

September 4, 2008

First Use in Commerce

September 4, 2008

Published for Opposition

September 29, 2015

Goods & Services

Manufacturing services for others in the area of pharmaceutical drug delivery systems, including continuous release, pulsatile release, extended release, sustained release, taste masked release, and delayed release systems, clinical manufacturing of drug formulations for others to support clinical trials, fabrication and preparation of active pharmaceutical ingredients for others, technology scale-up services for others, and integration of technology into manufacturing processes for others, all relating to multiple drug product formats, namely, semi-solids, solutions, suspensions, particulates, solid dispersions, solid solutions and injectables

Pharmaceutical drug delivery technology development services; pharmaceutical drug delivery technology development services, namely, research and development in the area of pharmaceutical drug delivery systems, including continuous release, pulsatile release, extended release, sustained release, taste masked release, and delayed release systems, consisting of selection of drug formulation and delivery systems to optimize performance of active pharmaceutical ingredients, analytic techniques to test drug formulations, analytic services to detect, identify and quantify drug components, stability testing, physical characterizations of formulations, in-vitro release testing, all relating to multiple drug product formats, namely, semi-solids, solutions, suspensions, particulates, solid dispersions, solid solutions and injectables

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Jul 19, 2025 NA89
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Jul 19, 2025 RNL1
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Jul 19, 2025 89AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jul 19, 2025 APRE
TEAS SECTION 8 & 9 RECEIVED
Feb 20, 2025 E89R
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Feb 14, 2025 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 14, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 14, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 14, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 14, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 14, 2025 COAR
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Dec 15, 2024 REM2
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Jul 6, 2021 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Jul 6, 2021 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jul 6, 2021 APRE
TEAS SECTION 8 & 15 RECEIVED
Feb 23, 2021 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Dec 15, 2020 REM1
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Oct 14, 2020 ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Oct 7, 2020 ASCK
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 26, 2016 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 26, 2016 COAR
REGISTERED-PRINCIPAL REGISTER
Dec 15, 2015 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 29, 2015 NPUB
PUBLISHED FOR OPPOSITION
Sep 29, 2015 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 9, 2015 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Aug 26, 2015 PREV
ASSIGNED TO LIE
Aug 26, 2015 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 8, 2015 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 7, 2015 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 7, 2015 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Aug 7, 2015 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Jul 1, 2015 GNFN
FINAL REFUSAL E-MAILED
Jul 1, 2015 GNFR
FINAL REFUSAL WRITTEN
Jul 1, 2015 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 16, 2015 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 15, 2015 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 15, 2015 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 19, 2014 GNRN
NON-FINAL ACTION E-MAILED
Dec 19, 2014 GNRT
NON-FINAL ACTION WRITTEN
Dec 19, 2014 CNRT
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 15, 2014 GNRN
NON-FINAL ACTION E-MAILED
Dec 15, 2014 GNRT
NON-FINAL ACTION WRITTEN
Dec 15, 2014 CNRT
ASSIGNED TO EXAMINER
Dec 14, 2014 DOCK
NOTICE OF PSEUDO MARK E-MAILED
Sep 13, 2014 MPMK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 12, 2014 NWOS
NEW APPLICATION ENTERED
Sep 5, 2014 NWAP